Dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur)).

Bioorg Med Chem Lett

Bristol-Myers Squibb, Route 206 & Provinceline Road, PO Box 4000, Princeton, NJ 08543-4000, USA.

Published: December 2008

A series of dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur)) have been identified. The synthesis, structure-activity relationships and selectivity against several other ion channels are described.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2008.10.099DOI Listing

Publication Analysis

Top Keywords

dihydropyrazolopyrimidine inhibitors
8
inhibitors kv15
8
kv15 ikur
8
ikur series
4
series dihydropyrazolopyrimidine
4
ikur identified
4
identified synthesis
4
synthesis structure-activity
4
structure-activity relationships
4
relationships selectivity
4

Similar Publications

Triazolo and imidazo dihydropyrazolopyrimidine potassium channel antagonists.

Bioorg Med Chem Lett

March 2013

Department of Discovery Chemistry, Bristol-Myers Squibb, Research and Development, PO Box 5400, Princeton, NJ 08543-5400, United States.

Previously disclosed C6 amido and benzimidazole dihydropyrazolopyrimidines were potent and selective blockers of IKur current. Syntheses and SAR for C6 triazolo and imidazo dihydropyrazolopyrimidines series are described. Trifluoromethylcyclohexyl N(1) triazole, compound 51, was identified as a potent and selective Kv1.

View Article and Find Full Text PDF

Dihydropyrazolopyrimidines containing benzimidazoles as K(V)1.5 potassium channel antagonists.

Bioorg Med Chem Lett

September 2009

Bristol-Myers Squibb, Pharmaceutical Research and Development, PO Box 5400, Princeton, NJ 08543-5400, USA.

Dihydropyrazolopyrimidines with a C6 heterocycle substituent were found to have high potency for block of K(V)1.5. Investigation of the substitution in the benzimidazole ring and the substituent in the 5-position of the dihydropyrazolopyrimidine ring produced 31a with an IC50 for K(V)1.

View Article and Find Full Text PDF

Dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur)).

Bioorg Med Chem Lett

December 2008

Bristol-Myers Squibb, Route 206 & Provinceline Road, PO Box 4000, Princeton, NJ 08543-4000, USA.

A series of dihydropyrazolopyrimidine inhibitors of K(V)1.5 (I(Kur)) have been identified. The synthesis, structure-activity relationships and selectivity against several other ion channels are described.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!